Jazz Pharmaceuticals plc
JAZZ
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic andā¦ read more
Healthcare
Biotechnology
18 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$131.16
Price-2.16%
-$2.89
1Y
Price
Market Cap
$7.970b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-49.2%
EBITDA Margin-68.7%
Net Profit Margin+9.7%
Free Cash Flow MarginRevenue
$4.087b
+0.4%
1y CAGR+3.8%
3y CAGR+7.4%
5y CAGREarnings
-$404.841m
-172.3%
1y CAGR+49.3%
3y CAGR+44.9%
5y CAGREPS
-$6.73
-177.8%
1y CAGR+44.8%
3y CAGR+42.4%
5y CAGRBook Value
$3.706b
$10.944b
Assets$7.238b
Liabilities$5.433b
DebtDebt to Assets
49.6%
12.1x
Debt to EBITDAFree Cash Flow
$1.265b
-6.1%
1y CAGR+19.4%
3y CAGR+15.9%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company